Isomorphic Labs
To add a bio or update company history, please click update information.
News from Isomorphic Labs
Isomorphic Labs
11 May 2026
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Isomorphic Labs
31 Mar 2025
Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.
Isomorphic Labs
- Life Sciences
- London, United Kingdom
- £1.9bn
- isomorphiclabs.com
- Update Information
More venture news
- 7 Jul 2026
Healome TherapeuticsHealome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences - 6 Jul 2026
Revolver TherapeuticsRevolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
EquityLife Sciences - 25 Jun 2026
RQ BioRQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences
